COGAZOCINE
UNII 6GKB767I3M

Substance Identification & Data

This profile provides standardized clinical and technical data for Cogazocine, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 6GKB767I3M.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 57653-29-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
6GKB767I3M
CAS Registry Number
57653-29-9
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
COGAZOCINE
Official standardized name for this substance within the FDA UNII nomenclature system.
InChIKey
C21H31NO
International Chemical Identifier digital signature for unique molecular identification.
SMILES String
IUUBFDSJJHOTDI-UHFFFAOYSA-N
Line notation for describing the chemical structure and connectivity of atoms.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
PubChem CID
Unique identification number in the NCBI database of chemical substances.
INN ID
4022
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
chemical
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Ingredient Role
C1(CCC1)CN2CCC3(c4c(CC2C3(C)C)ccc(c4)O)CC

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Cogazocine. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

COGAZOCINE

Common Names & Synonyms

3-(CYCLOBUTYLMETHYL)-6-ETHYL-1,2,3,4,5,6-HEXAHYDRO-11,11-DIMETHYL-2,6-METHANO-3-BENZAZOCIN-8-OL
COGAZOCINE [INN]